Impairment of language abilities is a common feature in autistic individuals. Heterozygous mutations in the Forkhead Box P2 (FOXP2) gene lead to a severe spoken language disorder. Recently, several studies have pinpointed the involvement of common variants of the Contactin-Associated Protein-Like 2 (CNTNAP2) gene, whose transcription is regulated by the product of FOXP2, in several disorders characterized by language impairments such as autism, specific language impairment (SLI), and selective mutism (SM). In the present study, common variants of the FOXP2 and the CNTNAP2 genes were analyzed through a case-control association study in 322 Spanish autistic patients and 524 controls. The results of this study suggest that common variants of FOXP2 are unlikely to contribute to autism susceptibility, in agreement with previous findings. Furthermore, we failed to replicate in our sample a previous association finding of two single nucleotide polymorphisms (rs2710102 and rs7794745) in the CNTNAP2 gene with autism. No evidence for the association of these genes with language traits was observed in our analysis.
Introduction
Language impairments represent a frequent feature of the autism phenotype, and a considerable proportion of autistic individuals remain nonverbal throughout life (Rapin and Dunn, 2003) . Several genes have been implicated in spoken language disorders, among others, Forkhead Box P2 (FOXP2) (7q31.1) and ContactinAssociated Protein-Like 2 (CNTNAP2) (7q35-7q36.1) (Newbury et al., 2010) . Interestingly, both genes map to chromosome 7q, where several linkage studies reported positive results in autism (Abrahams and Geschwind, 2008) . Heterozygous mutations in FOXP2 lead to a monogenic form of severe speech and language disorder (Lai et al., 2001) . This gene encodes a transcription factor involved in the regulation of numerous genes, including CNTNAP2, a member of the neurexin family (Vernes et al., 2008) . Recently, a homozygous mutation in CNTNAP2 has been reported in Old Order Amish children from several families with seizures, language regression, and pervasive developmental disorder (Strauss et al., 2006) . Copy Number Variants (CNVs) or chromosome rearrangements in this gene have been reported recently in a wide spectrum of neuropsychiatric disorders such as autism, attention deficit hyperactivity disorder (ADHD), schizophrenia, epilepsy, Gilles de la Tourette, and mental retardation (Newbury et al., 2010) . Moreover, two association studies suggest that common variants of CNTNAP2 may be involved in autism susceptibility: single nucleotide polymorphism (SNP) rs2710102 showed an association with the 'age at first word' trait in autistic patients (Alarcón et al., 2008) and rs7794745 was associated with autism in an independent sample (Arking et al., 2008) . A recent study suggests that rs2710102 may influence early language acquisition in the general population (Whitehouse et al., 2011) . In addition, Tan et al. (2010) found a reduction in the cortex gray matter volume in males of the general population, homozygous for the minor allele of rs7794745. The results of these studies converge on CNTNAP2, suggesting that common variants in this gene may be involved in autism and influence language traits. The crucial role of FOXP2 in human language development makes it an intriguing candidate gene for autism. For this reason, several mutation screening and association studies have been carried out (Newbury et al., 2002; Wassink et al., 2002; Gauthier et al., 2003; Gong et al., 2004; Li et al., 2005; Marui et al., 2005; Richler et al., 2006) , although only two studies in Chinese and Japanese autistic populations found a nominal association (Gong et al., 2004; Li et al., 2005) . However, none of these studies achieved a comprehensive genetic coverage of FOXP2.
In the present work, we carried out a case-control association study between autism and 12 tagSNPs across the FOXP2 gene and we also tested the markers rs7794745 and rs2710102 of CNTNAP2 for replication purposes. Furthermore, we also analyzed the possible contribution of these genes to specific language traits in our autism sample.
Materials and methods
The autism cohort under study included 322 unrelated individuals (269 men, 53 women; average age: 17 years) fulfilling the Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Text Revision (DSM-IV-TR) criteria for autism, Asperger disorder, or pervasive developmental disorder not otherwise specified on the basis of ADI-R (Autism Diagnostic Interview-Revised) and ADOS-G (Autism Diagnostic Observation Schedule-Generic) (Lord et al., 1994; Lord et al., 2000) . Five hundred and twenty-four frequency sex-matched unrelated controls were recruited at the Blood and Tissues Bank of the Hospital Universitari Vall d'Hebron. Patients and controls were Spanish and Caucasian. Genomic DNA was extracted from peripheral blood lymphocytes using the salting-out method.
We selected SNPs covering all exons, introns, and 3-5 kb sequences upstream and downstream of the FOXP2 gene. We minimized marker redundancy by evaluating linkage disequilibrium (LD) patterns and the distribution of haplotype blocks in the CEU population from the HapMap database project (release 20, www.hapmap.org). Twelve tagSNPs were selected with an r 2 value less than 0.85 from all SNPs with a minor allele frequency greater than 0.10. All markers in the FOXP2 gene were genotyped using an SNPlex assay (Applied Biosystems, Carlsbad, California, USA) at the Barcelona node of the National Genotyping Center (CeGen, www.cegen.org).
Two markers in CNTNAP2, rs2710102 and rs7794745, were genotyped through PCR-RFLP analysis. Enzyme restriction was performed with AvaI (rs2710102) and Tsp509I (rs7794745). The details of primer sequences and protocols are available upon request. Analyses of Hardy-Weinberg equilibrium and the case-control association study were carried out using the SNPassoc R package (Gonzalez et al., 2007) . Haplotype-based casecontrol analysis in the FOXP2 gene was carried out using Haploview 4.0 (Barrett et al., 2005) .
In addition, we assessed the possible genetic contribution of the studied markers to selected relevant variables of language traits in autism: 'age at first word' and 'age at first phrase'. These variables were checked for normality and homogeneity of variances using Kolmogorov-Smirnov and Levene tests, respectively. As 'age at first phrase' followed a normal distribution, the mean scores were compared among the different genotypes by one-way analysis of variance tests. For 'age at first word', in which normality was rejected, we used nonparametric tests (Kruskal-Wallis).
Results
We carried out a case-control association study of 14 SNPs in 322 patients and 524 controls to assess the genetic contribution of two language-related genes in autism. Twelve tagSNPs selected to capture the genetic variability of FOXP2 and two markers of CNTNAP2, associated previously with autism, were tested in our cohort. All markers passed quality control thresholds: genotyping call rate >90%, r 2 < 0.85 from any other tagSNP (FOXP2 gene), minor allele frequency >0.1, Hardy-Weinberg equilibrium (P > 0.01 in our control population). Genetic homogeneity in our sample was confirmed previously through the analysis of 46 unlinked genome-wide SNPs (Toma et al., 2011) .
The results of the case-control association study between single markers and autism are summarized in Table 1 . No SNP reached a nominal association in FOXP2 under the three genetic models considered in our analysis (additive, dominant, and recessive), with P-values ranging from 0.21 to 0.94. Also, no association was obtained for the two CNTNAP2 markers (P-values from 0.12 to 0.88). Similar results were obtained when we excluded the Asperger individuals from the data set (P-values from 0.08 to 0.97, data not shown). Also, no evidence for an association was found when we considered men and women separately. LD patterns across the FOXP2 gene are distributed in four LD blocks (block 1: rs12533005, rs10228350, rs10255943, rs10268637, rs10486026, and rs4727799; block 2: rs17137124 and rs1229761; block 3: rs7782412 and rs7799652; block 4: rs936146 and rs10953766). These blocks were assessed for association through haplotype analysis, but we failed to detect any association (all P > 0.05, data not shown).
Association study of autism and language genes Toma et al. 83 We also considered language endophenotypes in autistic individuals to gain more insight into the possible genetic influence of FOXP2 and CNTNAP2 on language impairments. The variable 'age at first word' did not show an association with any of the 14 markers considered (P > 0.05, data not shown), whereas two SNPs in FOXP2 showed a nominal association with 'age at first phrase' (rs17137124, P = 0.049 and rs7782412, P = 0.043) ( Table 2) . However, these results were not significant after applying the Bonferroni correction for multiple testing.
Discussion
During the last decade, the identification of mutations in FOXP2 in a severe and rare form of speech impairment has prompted several studies aimed at assessing its possible role in language impairments frequently associated with autism. None of these mutational screenings or association studies clearly implicated this gene in autism, with the exception of two SNPs showing a weak association in Asian populations (Gong et al., 2004; Li et al., 2005) . The casecontrol association study of 12 FOXP2 tagSNPs carried out here did not show a significant association with autism or specific language traits. Taken together, these data suggest that it is unlikely that common variants in FOXP2 may be at the genetic basis of autism. Despite this, recent findings highlight instead that low-frequency variants of FOXP2 may be involved in a few cases of autism spectrum disorders (Schaaf et al., 2011; Casey et al., 2012) .
FOXP2 regulates the transcription of CNTNAP2, a language-related gene that belongs to the neurexin family. Recently, de novo chromosomal rearrangements including CNTNAP2, but also other genes, have been described in autistic individuals with speech delay (Bakkaloglu et al., 2008; Rossi et al., 2008; Poot et al., 2009) . Moreover, deletions encompassing CNTNAP2 and several adjacent genes have been described in cases of schizophrenia and epilepsy associated with mental retardation and speech delay (Friedman et al., 2008) . These genetic rearrangements include several genes in addition to CNTNAP2, so it is likely that additional genes may contribute toward the cognitive impairments described in these patients. Interestingly, CNVs encompassing only the CNTNAP2 gene region have been found in patients with schizophrenia, epilepsy, or attention deficit hyperactivity disorder, in whom no language impairments were described (Friedman et al., 2008; Elia et al., 2010; Mefford et al., 2010) . Also, common and rare variants in CNTNAP2 have been implicated in autism: rare missense changes were identified in a few individuals (Bakkaloglu et al., 2008) and common variants were found to be associated with the disease: rs7794745 (Arking et al., 2008) and rs2710102 (Alarcón et al., 2008) . However, in our cohort of 322 autistic patients and 524 healthy individuals, these two SNPs were not found to be associated with autism or language traits. Insufficient genetic power because of limited sample size, heterogeneity among samples, or differences in the LD patterns among populations may explain the lack of replication.
In conclusion, we corroborate previous findings confirming that common variants of FOXP2 are not involved in susceptibility to autism. Moreover, we failed to replicate positive results of two common variants of the CNTNAP2 gene (rs2710102 and rs7794745) associated previously with autism and language traits, suggesting that further research is required to elucidate the role of this gene in autism.
